CC
LLY icon

Clearwave Capital’s Eli Lilly LLY Stock Holding History

Clearwave Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$796K Buy
663
+100
+18% +$102K 0.44% 52
2026
Q1 		$517K Buy
563
+82
+17% +$83.1K 0.35% 66
2025
Q4 		$517K Buy
+481
New +$460K 0.38% 69

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clearwave Capital's LLY Position: Q2 2026 in Review

Clearwave Capital increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $102K and bringing the position to 663 shares worth $796K. The position accounts for 0.44% of the portfolio, ranked #52.

Clearwave Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,595 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clearwave Capital held 663 shares of Eli Lilly worth $796K as of Q2 2026.
  • Clearwave Capital bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.44% of Clearwave Capital's portfolio in Q2 2026, its #52 holding.
  • Clearwave Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,595 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clearwave Capital's 13F filing for Q2 2026, filed 20 Jul 2026.